SOURCE: Healtheuniverse, Inc.

April 10, 2006 16:05 ET

Healtheuniverse Completes Acquisition of the California Institute of Cosmetic and Reconstructive Surgery; Revenue and Earnings Reflected in 2nd Quarter 2006 Financials

Acquisition Includes CICRS Clinical Database Advancing Capacity for Adult Stem Cell Clinical Trials

COVINA, CA -- (MARKET WIRE) -- April 10, 2006 -- Healtheuniverse Inc. (OTC: HLUN), a diversified biotechnology development firm specializing in the development and commercialization of patented biopharmaceutical and biomedical products, announced today that it has completed the acquisition of the assets, operations and clinical database of The California Institute of Cosmetic & Reconstructive Surgery. Revenue and Earnings from the acquisition will be reflected in the 2nd quarter financials and is expected to be accretive to earnings.

The acquisition includes the CICRS clinical database, which expands and advances the Company's capacity for evidence-based human clinical trials for stem cell applications in the plastic, reconstructive, and cosmetic surgery market. This acquisition marks a significant benchmark in the Companies progress to be the first to commercialize the use of regenerative medicine and adult stem cells.

Services at the California Institute of Cosmetic & Reconstructive Surgery range from the latest techniques in Cosmetic Surgery to extensive new developments in the field of Reconstructive Surgery. The Institute performs Cosmetic Surgery such as breast augmentation, facelifts, liposuction, and rhinoplasty, as well as extensive Reconstructive Surgery for Breast Cancer, burn victims, trauma victims, chronic wounds, skin cancer, and hand surgery.

Dr Vipul Dev MD, Chief Executive Officer of Healtheuniverse, Inc., stated, "The successful completion of the acquisition of CICRS is a significant milestone in the growth of Healtheuniverse. With substantial growth in the area of plastic and reconstructive surgery and our adult stem cell research moving towards clinical trials we believe the acquisition is a cornerstone to our development. We are now moving forward with our plans to accelerate development of our non-embryonic stem cell therapies, which should result in advancement of the technology and value for our shareholders."


HEALTHeUNIVERSE Inc. is a biotechnology development firm specializing in the development and commercialization of patented Biopharmaceutical and Biomedical products. We are engaged in research and development of regenerative medicine therapies using non-embryonic adult stem cells for use in plastic, reconstructive, orthopedic, vascular, and cardiac surgery. Healtheuniverse strives to be the first to commercialize the use of regenerative medicine in plastic and reconstructive surgery and to develop therapeutic uses in the most profitable commercial applications. More information on Healtheuniverse is available online at

Safe Harbor Statement

This press release contains statements, which may constitute "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of Healtheuniverse Inc., and members of their management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. Important factors currently known to management that could cause actual results to differ materially from those in forward-statements include fluctuation of operating results, the ability to compete successfully and the ability to complete before-mentioned transactions. The company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.

Contact Information

  • For more information, please contact:
    Healtheuniverse, Inc.
    Investor Relations
    Email Contact